Hospitals, Research Laboratories and Vaccines

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

Drug Topics

JUNE 10, 2025

“RSV disease is the leading cause of infant hospitalization in the US and can lead to serious respiratory conditions like bronchiolitis and pneumonia,” Octavio Ramilo, an investigator on the CLEVER and SMART trials., said in a release.

FDA

FDA Vaccines Adverse Reactions Specialty Pharmacies

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. Give your business an edge with our leading industry insights.

FDA

FDA Packaging Hospitals Research Laboratories

FDA approves MSD’s Keytruda to treat head and neck cancer

Pharmaceutical Technology

JUNE 16, 2025

GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

FDA

FDA Research Laboratories Communication Hospitals

Pharmacy Technician Pulse

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

FDA approves MSD’s Keytruda to treat head and neck cancer

Stay Connected